Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,460 across all filing types
Latest filing 2026-01-12 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
2026年第一次临时股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2026 first extraordinary shareholders meeting of Huabang Life Health Co., Ltd. It includes voting results on various proposals, meeting attendance, and legal opinions. The content focuses on the official results of shareholder votes at a general meeting, including detailed vote counts and percentages for each agenda item. There is no presentation material, financial statements, or management discussion, but rather the formal disclosure of voting outcomes. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document length is substantial and contains full voting results, not just a brief announcement or a notice of a report publication, so it is not RPA or RNS. Therefore, the correct classification is DVA with high confidence.
2026-01-12 Chinese
北京市时代九和律师事务所关于华邦生命健康股份有限公司2026年第一次临时股东会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening, procedures, attendees, and voting results of the 2026 first extraordinary shareholders meeting (临时股东会) of Huabang Life Health Co., Ltd. It details the legality and validity of the meeting's convocation, attendance, voting procedures, and results for various proposals, including financing and bond issuance matters. The document is not a full report like an annual or interim report, nor is it a simple announcement. It is a legal opinion related to the shareholders meeting and its resolutions, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document is lengthy (over 13,000 characters) and contains detailed voting results and legal validation, not just a brief announcement or a proxy solicitation. Therefore, the best classification is DVA.
2026-01-12 Chinese
关于控股股东部分股份质押展期的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the extension of a pledge on shares held by the controlling shareholder. It details the number of shares pledged, the pledge period extension, and related shareholder information. There are no financial statements, earnings data, or management discussion. The document is a formal disclosure about share pledge extension, which fits the category of a Regulatory Filing (RNS) as it is a compliance announcement related to share pledging and does not fit into more specific categories like capital changes or director dealings. The document length is short and it is an announcement rather than a report.
2026-01-05 Chinese
对外担保管理制度（2025年12月）
Governance Information Classification · 95% confidence The document is a detailed internal management system for external guarantees by the company 华邦生命健康股份有限公司. It outlines procedures, responsibilities, risk management, approval processes, and disclosure requirements related to external guarantees. It is a governance-related document focusing on internal rules and controls rather than financial results, earnings, or regulatory announcements. There is no indication that this is an announcement or a report publication notice. The content fits best under Governance Information (CGR) as it details the company's governance practices regarding external guarantees.
2025-12-23 Chinese
关于非公开发行科技创新可交换公司债券的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Huabang Life Health Co., Ltd. regarding a non-public issuance of technology innovation exchangeable corporate bonds. It details the bond issuance plan, legal compliance, authorization matters, and procedural steps. The document is a formal announcement of a capital raising activity involving bond issuance, including terms, conditions, and authorizations. It does not contain financial statements or quarterly/yearly financial results but focuses on financing activities and capital structure changes. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is 3803 characters, which is sufficient for a detailed announcement but not a full financial report.
2025-12-23 Chinese
关于召开2026年第一次临时股东会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about convening the 2026 first extraordinary general meeting (临时股东会) of Huabang Life Health Co., Ltd. It includes information about meeting time, location, voting procedures, agenda items, and proposals to be voted on, including financing and bond issuance matters. The document is a formal announcement to shareholders about the meeting and the items to be voted on, not the results of the vote or the meeting minutes. It does not contain financial statements or management discussion but focuses on the meeting logistics and agenda. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2025-12-23 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.